» Articles » PMID: 28664215

Anti-inflammatory Effect of Galectin-1 in a Murine Model of Atopic Dermatitis

Overview
Specialty General Medicine
Date 2017 Jul 1
PMID 28664215
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Key Messages: Pharmacological treatment with rGal-1 reduces clinical signs of atopic dermatitis. Systemic treatment with rGal-1 inhibits eosinophil and mast cell influx in the skin of AD animals. rGal-1 reduced local eotaxin levels and systemic IL-17 levels. The inhibition of disease progression induced by rGal-1 was correlated with upregulation of phosphorylated ERK.

Citing Articles

Neutrophils in Atopic Dermatitis.

Chiang C, Cheng W, Dela Cruz J, Raviraj T, Wu N, Korinek M Clin Rev Allergy Immunol. 2024; 67(1-3):21-39.

PMID: 39294505 PMC: 11638293. DOI: 10.1007/s12016-024-09004-3.


Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications.

Nowowiejska J, Baran A, Hermanowicz J, Sieklucka B, Pawlak D, Flisiak I Biomolecules. 2023; 13(10).

PMID: 37892153 PMC: 10604582. DOI: 10.3390/biom13101472.


Paraquat Induces Lung Injury miR-199-Mediated SET in a Mouse Model.

Cai Q, Jin Y, Jia Z, Liu Z Front Pharmacol. 2022; 13:856441.

PMID: 35431948 PMC: 9011139. DOI: 10.3389/fphar.2022.856441.


Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis.

Fernandez-Perez R, Lopez-Santalla M, Sanchez-Dominguez R, Alberquilla O, Gutierrez-Canas I, Juarranz Y Front Immunol. 2021; 12:687443.

PMID: 34262567 PMC: 8273429. DOI: 10.3389/fimmu.2021.687443.


The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.

Correa M, Areias L, Correia-Silva R, DAvila S, Leopoldino A, Greco K Cells. 2021; 10(4).

PMID: 33923930 PMC: 8073283. DOI: 10.3390/cells10040947.


References
1.
Delbrouck C, Doyen I, Belot N, Decaestecker C, Ghanooni R, de Lavareille A . Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration. Lab Invest. 2002; 82(2):147-58. DOI: 10.1038/labinvest.3780407. View

2.
Iqbal A, Cooper D, Vugler A, Gittens B, Moore A, Perretti M . Endogenous galectin-1 exerts tonic inhibition on experimental arthritis. J Immunol. 2013; 191(1):171-7. PMC: 3971374. DOI: 10.4049/jimmunol.1203291. View

3.
Kim H, Kim Y, Kang M, Seo J, Kim H, Jeong S . A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus. Exp Dermatol. 2012; 21(9):672-5. DOI: 10.1111/j.1600-0625.2012.01539.x. View

4.
Hsieh S, Ying N, Wu M, Chiang W, Hsu C, Wong T . Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene. 2008; 27(26):3746-53. DOI: 10.1038/sj.onc.1211029. View

5.
Heo W, Lee K, Hong J, Kim M, Oh M, Kim Y . The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis. Clin Exp Dermatol. 2015; 40(6):665-71. DOI: 10.1111/ced.12567. View